Literature DB >> 24448194

Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China.

Yongzhen Xiong1, Dong Wang2, Weiyan Lin3, Hao Tang3, Shaoli Chen2, Jindong Ni3.   

Abstract

The present study was performed to determine the seroprevalence of IgG measles antibodies in Dongguan residents (irrespective of vaccination status), to analyze the changes in age-related serological susceptibility patterns. A total of 1960 residents aged 0-60 years and 315 mother-infant pairs were studied. Serum IgG antibodies against measles virus were measured by ELISA. The overall seroprevalence was 93.4% in the general population in Dongguan, China. In subgroups aged 1-29 years who were likely vaccinated, there was a declining trend of seropositivity with age from 98.6% at 1-4 years to 85.7% at 20-29 years (P<0.0001). Seroprevalence were near or>95% in the older population (30-39 years and ≥ 40 years) who had not been immunized against measles. Age and sex were independent factors associated with seropositivity. Seroprevalence in pregnant women and their newborns was 87.0% and 84.1%, respectively. Our results suggest that the waning vaccine-induced immunity may be the main cause of increased serological susceptibility in young adults and young infants. An additional vaccination strategy that targets young adults is important for elimination of measles.

Entities:  

Keywords:  age distribution; antibody; measles; seroprevalence; vaccination

Mesh:

Substances:

Year:  2014        PMID: 24448194      PMCID: PMC4896514          DOI: 10.4161/hv.27734

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  16 in total

1.  The seroepidemiology of measles in Western Europe.

Authors:  H de Melker; R G Pebody; W J Edmunds; D Lévy-Bruhl; M Valle; M C Rota; S Salmaso; S van den Hof; G Berbers; P Saliou; P Crovari; I Davidkin; G Gabutti; L Hesketh; P Morgan-Capner; A M Plesner; M Raux; A Tische; E Miller
Journal:  Epidemiol Infect       Date:  2001-04       Impact factor: 2.451

2.  The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits.

Authors:  P W Kelley; B P Petruccelli; P Stehr-Green; R L Erickson; C J Mason
Journal:  JAMA       Date:  1991-11-20       Impact factor: 56.272

3.  Low measles seropositivity rate among children and young adults: a sero-epidemiological study in southern China in 2008.

Authors:  Chuanxi Fu; Jianxiong Xu; Weibin Liu; Wei Zhang; Ming Wang; Jun Nie; von Kries Rüdiger
Journal:  Vaccine       Date:  2010-08-03       Impact factor: 3.641

4.  Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.

Authors:  M A Almuneef; Z A Memish; H H Balkhy; B Otaibi; M Helmi
Journal:  Infect Control Hosp Epidemiol       Date:  2006-10-17       Impact factor: 3.254

Review 5.  Measles outbreak in Europe: susceptibility of infants too young to be immunized.

Authors:  E Leuridan; M Sabbe; P Van Damme
Journal:  Vaccine       Date:  2012-07-26       Impact factor: 3.641

6.  Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

Authors:  H A Gans; A M Arvin; J Galinus; L Logan; R DeHovitz; Y Maldonado
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

7.  Serological surveillance of measles in blood donors in Rio de Janeiro, Brazil.

Authors:  Rosângela Castro-Silva; Luiz Antonio Bastos Camacho; Luiz Amorim; Andréia Dantas Medeiros; Daise Almeida Ferreira; Solange Artimos Oliveira; Marilda M Siqueira
Journal:  Rev Panam Salud Publica       Date:  2003-11

Review 8.  Feasibility of global measles eradication after interruption of transmission in the Americas.

Authors:  Ciro A de Quadros; Jon Kim Andrus; M Carolina Danovaro-Holliday; Carlos Castillo-Solórzano
Journal:  Expert Rev Vaccines       Date:  2008-04       Impact factor: 5.217

9.  Immunity against measles in populations of women and infants in Poland.

Authors:  Wieslawa Janaszek; Janusz Slusarczyk
Journal:  Vaccine       Date:  2003-06-20       Impact factor: 3.641

10.  Sex differences in the humoral antibody response to live measles vaccine in young adults.

Authors:  M S Green; T Shohat; Y Lerman; D Cohen; R Slepon; P Duvdevani; N Varsano; R Dagan; E Mendelson
Journal:  Int J Epidemiol       Date:  1994-10       Impact factor: 7.196

View more
  11 in total

1.  Measles outbreak prevention and control among adults: Lessons from an importation outbreak in Yunnan province, China, 2015.

Authors:  Zhixian Zhao; Rongrong Zhou; Wen Yu; Liqun Li; Qiongfen Li; Pei Hu
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

2.  Evaluating Measles Incidence Rates Using Machine Learning and Time Series Methods in the Center of Iran, 1997-2020.

Authors:  Javad Nazari; Parnia-Sadat Fathi; Nahid Sharahi; Majid Taheri; Payam Amini; Amir Almasi-Hashiani
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

3.  Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.

Authors:  Ravit Bassal; Victoria Indenbaum; Rakefet Pando; Tal Levin; Eilat Shinar; Doron Amichay; Mira Barak; Anat Ben-Dor; Adina Bar Haim; Ella Mendelson; Dani Cohen; Tamy Shohat
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

4.  The epidemiological and serological characteristics of measles in Dongguan, China, 2005-2014.

Authors:  Ke Han; Shaoli Chen; Cuifei Tang; Jinjun Wen; Jingquan Li; Jindong Ni; Xueli Zheng
Journal:  Hum Vaccin Immunother       Date:  2016-03-22       Impact factor: 3.452

5.  Measles immunity in the China-Myanmar border region, Lincang city, Yunnan province, 2017.

Authors:  Rongrong Zhou; Shuyi Yuan; Wen Yu; Liqun Li; Qiongfen Li; Licun Guo; Zhixian Zhao; Zhizhong Song
Journal:  Hum Vaccin Immunother       Date:  2019-10-29       Impact factor: 3.452

6.  Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia.

Authors:  Waleed H Mahallawi; Nadir A Ibrahim
Journal:  Hum Vaccin Immunother       Date:  2021-02-11       Impact factor: 3.452

7.  Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing.

Authors:  Qing-Hong Meng; Ying Liu; Jin-Qian Yu; Li-Jun Li; Wei Shi; Ying-Jie Shen; Li Li; Shi-Na Zhan; Fan Yang; Ya-Juan Wang; Kai-Hu Yao
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

8.  Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.

Authors:  Mioljub Ristić; Vesna Milošević; Snežana Medić; Jelena Djekić Malbaša; Smiljana Rajčević; Jasmina Boban; Vladimir Petrović
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

9.  Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.

Authors:  Í Ödemiş; Ş Köse; Í Akbulut; H Albayrak
Journal:  Rev Esp Quimioter       Date:  2019-10-23       Impact factor: 1.553

Review 10.  Vertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators.

Authors:  Marie Albrecht; Petra Clara Arck
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.